Hints and tips:
...US President Joe Biden has put his fight against Big Pharma at the centre of his re-election campaign, championing his efforts to lower drug prices through the Inflation Reduction Act....
...Owning 50 shares at $2 apiece is no different to holding 100 shares at $1 each — or, in the case of Chipotle, one at $2,900 versus 50 at $58. Nor does it do anything to performance....
Swiss pharma group acquires rights to develop and manufacture bowel disease treatment
...But pressure is mounting on pharma companies to switch to synthetic substances as populations decline for horseshoe crabs and seabirds that eat the creatures’ eggs....
...The group this year sold its stake in vaccines maker Medicago amid suggestions that its involvement was holding back the company’s progress. The business of corporate transformation can’t be rushed....
...India’s biggest IPO so far this year has been a Rs43.2bn ($525mn) flotation by Mankind Pharma....
...“We could not be more excited,” Cook said at the China Development Forum in Beijing, the country’s version of Davos, which Beijing is holding offline for the first time since the pandemic began....
...It also sold $2.3bn of shares in the second quarter, cutting its stakes in General Motors, US Bancorp and grocer Kroger, and exited its positions in Verizon and Royalty Pharma....
...The largest by some distance is a 0.3 per cent stake in Pfizer held by Canada’s BMO Global Asset Management, worth $1.04bn, while Achmea’s largest pharma holding is a 0.01 per cent stake in J&J valued at...
...Donald Trump’s allies alleged a grand conspiracy between Democratic elites and Pfizer, which they accused of holding back the news until after the election to damage his prospects of a second term....
...But all that investment, including the acquisition of Kite Pharma for $12bn in 2017, has yet to deliver commercially....
...The California-based pharma’s renewed focus on oncology led it to acquire Kite Pharma for $12bn in 2017, adding a cutting edge cancer treatment to its portfolio....
...Warren Buffett’s Berkshire Hathaway placed a $5.7bn bet on four US pharmaceutical stocks in the third quarter, as the billionaire investor dumped holdings in several of the largest US banks....
...This is just the latest deal in a post-bubble spree spanning food, pharma and finance: think Daiichi-Sankyo and Ranbaxy, Kirin and Schincariol and Toshiba and Westinghouse....
...But it became obvious AstraZeneca could not pay any more in cash for such a large deal and nor could most Big Pharma companies....
...It is not, as Dr Bourla has done, to dump 62 per cent of your entire holdings within three months of putting the plan in place. Dr Bourla is not the only pharma CEO to be cashing out this year....
...Rock Holdings, a private entity he controls, will own more than three-quarters of the voting power, according to filings....
...(FT) Holdout heroes Elliott Management, the king of holding out until it gets what it wants, scored itself a nice Christmas bonus....
...That compared with $107bn on 177 deals in 2019 — heavily boosted by pharma group Takeda’s completion of its £46bn acquisition of Ireland’s Shire — and $24bn on 152 deals in 2018, according to Dealogic....
...Many of the defendants have teamed up to offer $48bn to settle these suits — but so far, many states are holding out for more....
...AstraZeneca Plc has made a preliminary approach to rival drugmaker Gilead Sciences Inc. about a potential merger, according to people familiar with the matter, in what would be the biggest health-care deal...
...SF Holding Sector: delivery logistics / HQ: Shenzhen, China Key stat: SF Holding posted 39.6 per cent revenue growth in the first quarter. SF Holding runs China’s most reliable courier operation....
...This dual role of holding consumer and health data is already the subject of a lawsuit against Google and the University of Chicago....
...The combination will be 57 per cent owned by Pfizer shareholders, with Mylan investors holding the remaining 43 per cent....
...Total ETF holdings of gold are 20% higher than they were when we worried about positioning back in January....
International Edition